UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040037
Receipt number R000045036
Scientific Title A Single-arm Trial Investigating the Effectiveness of VR(Virtual Reality)-based Cognitive Behavioral Therapy (VR-CBT) for Adult Depression
Date of disclosure of the study information 2020/04/03
Last modified on 2020/04/03 01:18:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Single-arm Trial Investigating the Effectiveness of VR(Virtual Reality)-based Cognitive Behavioral Therapy (VR-CBT) for Adult Depression

Acronym

VR-CBT study

Scientific Title

A Single-arm Trial Investigating the Effectiveness of VR(Virtual Reality)-based Cognitive Behavioral Therapy (VR-CBT) for Adult Depression

Scientific Title:Acronym

VR-CBT study

Region

Japan


Condition

Condition

Depression

Classification by specialty

Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical effectiveness of VR(Virtual Reality)-based CBT on Japanese adults with depression

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Beck Depression Inventory-2 (BDI-2)

Key secondary outcomes

PHQ-9
GAD-7
SDS
PDQ-5
CSQ-8


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Weekly VR-based group CBT over six weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Regular access to the Internet
2) A score of 10 or more on the PHQ-9
3) Ability to both understand and agree
with informed consent in Japanese

Key exclusion criteria

1) Receiving any other CBT intervention
during the trial
2) Strong suicidal ideation
3) Schizophrenia
4) Dementia
5) Any substance addiction (except
nicotine addiction) during the 12
months prior to the trial
6) (For patients receiving treatment by a
mental health practitioner)
Unavailability of practitioner's
permission for the patient to
participate in the trial

Target sample size

20


Research contact person

Name of lead principal investigator

1st name So
Middle name
Last name Mirai

Organization

Tokyo Dental College

Division name

Department of Psychiatry, Ichikawa General Hospital

Zip code

272-8513

Address

5-11-13, Sugano,Ichikawa, Chiba, 272-8513, Japan

TEL

0473220151

Email

somirai@tdc.ac.jp


Public contact

Name of contact person

1st name So
Middle name
Last name Mirai

Organization

Tokyo Dental College

Division name

Department of Psychiatry, Ichikawa General Hospital

Zip code

272-8513

Address

5-11-13, Sugano,Ichikawa, Chiba, 272-8513, Japan

TEL

0473220151

Homepage URL

https://peraichi.com/landing_pages/view/vrcbt?fbclid=IwAR0jEiVf9ubGIUB7CRxpGi9k9myJ-8ycN34cvvu1D5Ptz

Email

somirai@tdc.ac.jp


Sponsor or person

Institute

Department of Psychiatry, Tokyo Dental College Ichikawa General Hospital

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiramatsu Memorial Hospital

Address

1-20 Minami 22 Nishi 14, Sapporo, Hokkaido, Japan

Tel

011-561-0708

Email

terae@hiramatsu-mhp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 02 Month 01 Day

Date of IRB

2020 Year 01 Month 31 Day

Anticipated trial start date

2020 Year 02 Month 14 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 04 Month 03 Day

Last modified on

2020 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045036


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name